Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,973,425
-$2,223,038 QoQ
Shares Held
60,813
-44.9% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 275 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. KYMR ranks #64 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in KYMR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,973,425 | 60,813 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,196,463 | 110,415 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $9,084,081 | 116,747 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $4,517,075 | 79,807 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,089,656 | 47,884 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,151,591 | 42,075 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,236,347 | 30,732 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,758,284 | 163,919 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $890,543 | 29,834 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,557,352 | 113,367 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $715,145 | 28,089 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $509,114 | 36,627 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $699,584 | 30,430 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,614,469 | 189,486 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $336,784 | 13,493 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $293,806 | 13,496 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $267,055 | 13,563 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $650,499 | 15,371 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $966,633 | 15,225 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $904,359 | 15,396 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $449,303 | 9,264 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||